Abstract:OBJECTIVE To construct a novel biomimetic calcium phosphate (BioCaP) scaffold loaded with bone morphogenetic protein-2 (BMP-2), and to investigate its role in the osteogenesis of human adipose-derived stem cells (hASCs) in vitro and in vivo. METHODS The BioCaP scaffold coprecipitated with BMP-2 (BMP-2-BioCaP) was constructed in this study. Field emission scanning electron microscopy (SEM) was used to analyze the morphology of the surfaces. The release kinetics was measured to evaluate the slow-release characteristics in vitro. BMP-2-BioCaP was immersed in proliferation medium (PM) or osteogenic medium (OM), respectively. The supernatants were collected and used to culture hASCs in vitro. Cell numbers were determined using the cell-counting kit-8 (CCK-8) to assess the cell proliferation. After 7 and 14 days, alkaline phosphatase (ALP) staining and quantification were performed to test the activity of ALP. After 14 and 21 days, the calcification deposition was determined by alizarin red S (ARS) staining and quantification. The expressions of the osteoblast-related genes were tested on day 4 and day 14. In the in vivo study, 6 nude mice were used and implanted subcutaneously into the back of the nude mice for 4 groups: (1) BioCaP scaffold only, (2) BioCaP scaffold+hASCs, (3) BMP-2-BioCaP scaffold, (4) BMP-2-BioCaP scaffold+hASCs (test group). After 4 weeks of implantation, hematoxylin-eosin (HE) staining was performed to evaluate the in vivo osteogenesis of hASCs. RESULTS SEM observations showed that BioCaP and BMP-2-BioCaP scaffold were entirely composed of straight, plate-like and sharp-edged crystal units, and the length of the crystal units varied between 5 and 10 μm. Release kinetics analysis demonstrated that BMP-2 incorporated with BioCaP could be released at certain concentration and last for more than 21 days, and the accumulative protein release could reach 20%. CCK-8 assays showed that cell proliferation was not significantly affected by BMP-2-BioCaP. ALP activity was higher by the induction of OM+BMP-2-BioCaP than of the other groups (P<0.01). More mineralization deposition and more expressions of osteoblast-related genes such as Runt-related transcription factor 2 (RUNX2), ALP, osteopontin (OPN) and osteocalcin (OC) were determined in the OM+BMP-2-BioCaP group at different time points (P<0.01). HE staining showed that, in the test group and BMP-2-BioCaP scaffold group, the extracellular matrix (ECM) with eosinophilic staining were observed around hASCs, and newly-formed bone-like tissues could be found in ECM around the scaffold materials. Moreover, compared with the BMP-2-BioCaP scaffold group, more bone-like tissues could be observed in ECM with typical structure of bone tissue in the test groups. No obvious positive results were found in the other groups. CONCLUSION BMP-2-BioCaP scaffold could achieve slow-release of BMP-2 and promote the osteogenic differentiation of hASCs in vitro and in vivo. The novel tissue-engineered bone composed of hASCs and BMP-2-BioCaPis promising for the repair of bone defect.

Co-transfection with <i>BMP2</i> and <i>FGF2</i> via chitosan nanoparticles potentiates osteogenesis in human adipose-derived stromal cells <i>in vitro</i>

Studies on Recombinant Human Bone Morphogenetic Protein 2 Loaded Nano-Hydroxyapatite/Silk Fibroin Scaffolds

Adhesion of Bone Morphogenetic Protein-2-transfected MG 63 Cells to Chitosan Membranes

Cell Biocompatibility of Hydroxyapatite/Silk Fibroin Composite Scaffolds Carrying Bone Morphogenetic Protein

Adipose-derived Stem Cell Sheets Combined with Β-Tricalcium Phosphate/collagen-I Fiber Scaffold Improve Cell Osteogenesis.

Synergistic effects of fibroblast growth factor-2 and bone morphogenetic protein-2 on bone induction

Synergistic effect between 2-N,6-O-sulfonated chitosan and bone morphogenetic protein-2

Surface functionalization of nanoporous alumina with bone morphogenetic protein 2 for inducing osteogenic differentiation of mesenchymal stem cells.

Hypoxia Induces Osteogenesis in Rabbit Adipose-Derived Stem Cells Overexpressing Bone Morphogenic Protein-2.

Synergistic Effect of QNZ, an Inhibitor of NF-kappa B Signaling, and Bone Morphogenetic Protein 2 on Osteogenic Differentiation in Mesenchymal Stem Cells through Fibroblast-Induced Yes-Associated Protein Activation

Directional differentiation of adipose mesenchymal stem cells into osteoblasts induced by adenovirus-bone morphogenetic protein 2 gene transfection

[Promoted Role of Bone Morphogenetic Protein 2/7 Heterodimer in the Osteogenic Differentiation of Human Adipose-Derived Stem Cells].

Adipose-derived Stem Cells Transfected by Adenoviral Vector Mediated Human Transforming Growth Factor-Β1 Gene with Β-Tricalcium Phosphate Scaffold in Vitro

Sustained delivery of BMP-2 enhanced osteoblastic differentiation of BMSCs based on surface hydroxyapatite nanostructure in chitosan-HAp scaffold

Effects of Different Ratios of BMP2 and VEGFA on the Osteogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells

Bone morphogenetic protein 2 co-transfected with bone morphogenetic protein 7 for osteogenic differentiation of bone marrow mesenchymal stem cells

Effects of heterodimeric bone morphogenetic protein-2/7 on osteogenesis of human adipose-derived stem cells.

[A Novel Tissue-Engineered Bone Constructed by Using Human Adipose-Derived Stem Cells and Biomimetic Calcium Phosphate Scaffold Coprecipitated with Bone Morphogenetic Protein-2].

Paper 125: Use of Ad-Osf2 Modified Adipose-derived Stem Cells to Enhance Tendon-Bone Integration in the Reconstruction of ACL

Affinity-selected polysaccharide for rhBMP-2-induced osteogenesis via BMP receptor activation

Regulation of adipose-derived adult stem cells differentiating into chondrocytes with the use of rhBMP-2.